Experience with indole-3-carbinol used to treat diseases of the breast and to prevent breast cancer
- Authors: Smetnik A.A.1, Smetnik V.P.1, Kiselev V.I.2
-
Affiliations:
- Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
- Peoples' Friendship University of Russia
- Issue: No 2 (2017)
- Pages: 106-112
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247904
- DOI: https://doi.org/10.18565/aig.%202017.2.106-12
- ID: 247904
Cite item
Abstract
Full Text
About the authors
Antonina Alexandrovna Smetnik
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: a_smetnik@oparina4.ru
PhD, a senior researcher at the Department of Gynecological Endocrinology
Vera Petrovna Smetnik
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: v_smetnik@oparina4.ru
MD, Professor, Chief Researcher at the Department of Gynecological Endocrinology
Vsevolod Ivanovich Kiselev
Peoples' Friendship University of Russia
Email: vkis10@mail.ru
Doctor of Biological Sciences, professor, corresponding member of Russian Academy of Sciences, Deputy Director of Institute of Biomedical Problems
References
- Thomson C.A., Ho E., Strom M.B. Chemopreventive properties of 3,3’-diin-dolylmethane in breast cancer: evidence from experimental and human studies. Nutr. Rev. 2016; 74(7): 432-43.
- Karikas G. Chemoprevention molecular and biochemical mechanisms involved in cancer control and management. Health Sci. J. 2011; 5(2): 149-56.
- Wong G.Y., Bradlow L., Sepkovic D., Mehl S., Mailman J., Osborne M.P. Dose-ranging study of indole-3-carbinol for breast cancer prevention. J. Cell Biochem. Suppl. 1997; 28-29: 111-6.
- Licznerska B., Baer-Dubowska W. Indole-3-carbinol and its role in chronic diseases. Adv. Exp. Med. Biol. 2016; 928: 131-54.
- Haefele A., Word B., Yongmei X., Hammons G.J., Lyn-Cook B.D. Indole-3-carbinol (I3C) modulates expression of DNA methyltransferases 1, 3a, and 3b in pancreatic cancer cells: Effects of gender and a novel (C®T) polymorphism in the promoter region of DNMT 3b. Int. J. Cancer Prevention. 2007; 2: 245-55.
- Beaver L.M., Yu T.W., Sokolowski E.I., Williams D.E., Dashwood R.H., Ho E. 3,3’-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacety-lase activity in prostate cancer cells. Toxicol. Appl. Pharmacol. 2012; 263(3): 345-51.
- Fuentes F., Paredes-Gonzalez X., Kong A.T. Dietary glucosinolates sulfora-phane, phenethyl isothiocyanate, indole-3-carbinol/ 3,3’-diindolylmethane: anti-oxidative stress/ inflammation, nrf2, epigenetics/epigenomics and in vivo cancer chemopreventive efficacy. Curr. Pharmacol. Rep. 2015; 1(3): 179-96.
- Terry P., Wolk A., Persson I., Magnusson C. Brassica vegetables and breast cancer risk. JAMA. 2001; 285(23): 2975-7.
- Van Poppel G., Verhoeven D.T., Verhagen H., Goldbohm R.A. Brassica vegetables and cancer prevention. Epidemiology and mechanisms. Adv. Exp. Med. Biol. 1999; 472: 159-68.
- Verhagen H., Poulsen H.E., Loft S., van Poppel G., Willems M.I., van Bladeren PJ. Reduction of oxidative DNA-damage in humans by brussels sprouts. Carcinogenesis. 1995; 16(4): 969-70.
- Cohen J. H., Kristal A.R., Stanford J.L. Fruit and vegetable intakes and prostate cancer risk. J. Natl. Cancer Inst. 2000; 92: 61-8.
- Anderton M.J., Manson M.M., Verschoyle R.D., Gescher A., Lamb J.H., Farmer P.B. et al. Pharmacokinetics and tissue disposition of indole-3-carbi-nol and its acid condensation products after oral administration to mice. Clin. Cancer Res. 2004; 10(15): 5233-41.
- Wattenberg L.W., Loub W.D. Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles. Cancer Res. 1978; 38: 1410-3.
- Banerjee S., Kong D., Wang Z., Bao B., Hillman G.G., Sarkar F.H. Attenuation of multi-targeted proliferation linked signaling by 3,3’-diindolylmethane (DIM): from bench to clinic. Mutat. Res. 2011; 728(1-2): 47-66.
- Loub W.D., Wattenberg L.W., Davis D.W. Aryl hydrocarbon hydroxylase induction in rat tissues by naturally occurring indoles of cruciferous plants. J. Natl. Cancer Inst. 1975; 54(4): 985-8.
- Sepkovic D.W., Bradlow H.L. Estrogen hydroxylation - the good and the bad. Ann. N.Y. Acad. Sci. 2009; 1155: 57-67.
- Szaefer H., Licznerska B., Krajka-Kuzniak V., Bartoszek A., Baer-Dubowska W. Modulation of CYP1A1, CYP1A2 and CYP1B1 expression by cabbage juices and indoles in human breast cell lines. Nutr. Cancer. 2012; 64(6): 879-88.
- Lord R.S., Bongiovanni B., Bralley J.A. Estrogen metabolism and the diet-cancer connection: rationale for assessing the ratio of urinary hydroxylated estrogen metabolites. Altern. Med. Rev. 2002; 7(2): 112-29.
- Liu X., Lv K. Cruciferous vegetables intake is inversely associated with risk of breast cancer: a meta-analysis. Breast. 2013; 22(3): 309-13.
- Weaver Z., Montagna C., Xu X., Howard T., Gadina M., Brodie S.G. et al. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer. Oncogene. 2002; 21(33): 5097-107.
- Crowe D.L., Lee M.K. New role for nuclear hormone receptors and coactivators in regulation of BRCA1-mediated DNA repair in breast cancer cell lines. Breast Cancer Res. 2006; 8: R1.
- Scully R. Role of BRCA gene dysfunction in breast and ovarian cancer predisposition. Breast Cancer Res. 2000; 2(5): 324-30.
- Fan S., Wang J., Yuan R., Ma Y., Meng Q., Erdos M.R. et al. BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science. 1999; 284(5418): 1354-6.
- Knudson A.G. Mutation and cancer: Statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA. 1971; 68(4): 820-3.
- Zheng L., Annab L.A., Afshari C.A., Lee W.H., Boyer T.G. BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor. Proc. Natl. Acad. Sci. 2001; 98(17): 9587-92.
- Jones L.P, Li M., Halama E.D., Ma Y., Lubet R., Grubbs C.J. et al. Promotion of mammary cancer development by tamoxifen in a mouse model of BRCA1-mutation related breast cancer. Oncogene. 2005; 24(22): 3554-62.
- Meng Q., Qi M., Chen D.Z., Yuan R., Goldberg I.D., Rosen E.M. et al. Supression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes. J. Mol. Med. 2000; 78(3): 155-65.
- Kotsopoulos J., Zhang S., Akbari M., Salmena L., Llacuachaqui M., Zeligs M. et al. BRCA1 mRNA levels following a 4-6-week intervention with oral 3,3’-diindolylmethane. Br. J. Cancer. 2014; 111(7): 1269-74.
- Coupier I., Baldeyron C., Rousseau A., Mosseri V., Pages-Berhouet S., Caux-Moncoutier V. et al. Fidelity of DNA double-strand break repair in heterozygous cell lines harbouring BRCA1 missense mutations. Oncogene. 2004; 23(4): 914-
- Dalessandri K.M., Firestone G.L., Fitch M.D., Bradlow H.L., Bjeldanes L.F. Pilot study: effect of 3,3’-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer. Nutr. Cancer. 2004; 50(2): 161-7.
- Zeligs M.A., Brownstone P.K., Sharp M.E., Westerlind K.S., Wilson S.M., Johs S.M. Managing cyclical mastalgia with absorbable diindolylmethane:a randomized, placebo-controlled trial. J. Am. Nutr. Assoc. 2005; 8(1): 5-15.
- Plu-Bureau G., Lê M.G., Sitruk-Ware R., Thalabard J.C. Cyclical mastalgia and breast cancer risk: results of a French cohort study. Cancer Epidemiol. Biomarkers Prev. 2006; 15(6): 1229-31.
- Meng Q., Yuan F., Goldberg I.D., Rosen E.M., Auborn K., Fan S. Indole-3-carbinol is a negative regulator of estrogen receptor-alpha signaling in human tumor cells. J. Nutr. 2000; 130(12): 2927-31.
- Черниченко И.И., Кулакова Ю.А. Альтернативная терапия доброкачественной патологии молочных желез у женщин репродуктивного и пери-и постменопаузального возрастов. В кн.: Материалы Х Юбилейного международного конгресса по репродуктивной медицине (19-22 января 2016г., Москва). М.; 2016: 137-9. [Chernichenko I.I., Kulakova Yu.A. Alternative therapy of benign breast disease in women of reproductive and peri-and postmenopausal ages. In: Proceedings of the X Anniversary International Congress on Reproductive Medicine (January 19-22, 2016, Moscow). Moscow; 2016: 137-9. (in Russian)]
- Bradlow H.L., Zeligs M.A. Diindolylmethane (DIM) spontaneously forms from indole-3-carbinol (I3C) during cell culture experiments. In Vivo. 2010; 24(4): 387-91.